Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch... see more

TSX:SVA - Post Discussion

Sernova Corp > 1.20
View:
Post by Ekenbullets on Sep 16, 2021 6:21am

1.20

Lets hope 1.20 will hold at the end of the day...
Comment by Charly50 on Sep 16, 2021 6:31am
Nah dran Teile die Neuigkeiten          Pressemitteilung - 16. September 2021 Sernova unterzeichnet Kooperationsvereinbarung zur Weiterentwicklung konform beschichteter immungeschtzter therapeutischer Zellen fr Diabetes mit der University of Miami
Comment by Ekenbullets on Sep 16, 2021 6:48am
Yes lets see if 1.20 holds...i doubt it.
Comment by Charly50 on Sep 16, 2021 7:12am
Have you read the press release from just now?
Comment by Ekenbullets on Sep 16, 2021 7:28am
Yes. It makes me believe that a real deal is even further away than expectations hence the drop of stock. 
Comment by Charly50 on Sep 16, 2021 7:48am
sorry, but I see it differently. "While the studies will focus on immune protection of insulin producing cells in the Cell Pouch, these technology advances are expected to be directly relevant and applicable to an array of cell technologies for treatment of multiple cell therapy applications."
Comment by Ekenbullets on Sep 16, 2021 7:59am
Dont be sorry. Im not saying its bad news if you look at it in isolation, its a key to get rid of immosupression. But thats for the long play, I think stock will get beaten in the short term. 
Comment by BioTeck on Sep 16, 2021 12:22pm
30.10.2100 sounds about right Chuck. It'll be quiet for a few months again until spillup decides to put out another non news release. Ask yourself what this news tells us? Tells me we had bought this technology a long time ago. Didn't do anything with it. Now we hired the people who we bought it from to help us with it 2 years later. It doesn't say they have applied it to cells in the ...more  
Comment by rixpix on Sep 16, 2021 5:54pm
Thing I love the most about these markets is they never do what you expect them to do. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities